Neurocrine Biosciences Inc. Earnings

Neurocrine Biosciences Inc.’s revenue jumped 28.33% since last year same period to $805.5Mn in the Q4 2025. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated 1.33% jump in its revenue since last 3-months.

Neurocrine Biosciences Inc.’s net profit jumped 49.08% since last year same period to $153.7Mn in the Q4 2025. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated -26.63% fall in its net profits since last 3-months.

Neurocrine Biosciences Inc.’s net profit margin jumped 16.17% since last year same period to 19.08% in the Q4 2025. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated -27.6% fall in its net profit margins since last 3-months.

Neurocrine Biosciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.42 - a -23.66% fall from last quarter’s estimates.

Neurocrine Biosciences Inc.’s earning per share (EPS) estimates for the current year stand at 1.42.

Neurocrine Biosciences Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Neurocrine Biosciences Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.